|
MED30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.166200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.592570E-04 |
| Normal-vs-Stage2 |
1.418010E-01 |
| Normal-vs-Stage3 |
8.865400E-01 |
| Normal-vs-Stage4 |
3.553600E-01 |
| Stage1-vs-Stage2 |
1.117650E-01 |
| Stage1-vs-Stage3 |
1.908170E-02 |
| Stage1-vs-Stage4 |
2.956400E-01 |
| Stage2-vs-Stage3 |
3.692600E-01 |
| Stage2-vs-Stage4 |
8.273800E-01 |
| Stage3-vs-Stage4 |
6.369800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.638960E-03 |
| Normal-vs-AfricanAmerican |
1.103880E-02 |
| Normal-vs-Asian |
1.933430E-01 |
| Caucasian-vs-AfricanAmerican |
8.608600E-01 |
| Caucasian-vs-Asian |
9.115200E-01 |
| AfricanAmerican-vs-Asian |
9.518000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.57879999999055E-05 |
| Normal-vs-Female |
9.005400E-01 |
| Male-vs-Female |
1.792520E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.104350E-01 |
| Normal-vs-Extreme_Weight |
1.038140E-03 |
| Normal-vs-Obese |
4.942200E-02 |
| Normal-vs-Extreme_Obese |
2.541000E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.838000E-01 |
| Normal_Weight-vs-Obese |
9.108600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.159800E-01 |
| Extreme_Weight-vs-Obese |
2.236200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.756400E-01 |
| Obese-vs-Extreme_Obese |
1.724400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.713400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.392000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.594300E-04 |
| Normal-vs-Age(81-100Yrs) |
3.401800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.418800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.733900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.295020E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.343600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.122600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.498200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.774150E-04 |
| Normal-VS-Type2 PRCC |
2.062900E-03 |
| Normal-VS-KIRP CIMP |
3.636200E-01 |
| Normal-VS-Unclassified PRCC |
1.595960E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.845400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.603530E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.534400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.903050E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.497000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.012200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.399510E-04 |
| Normal-vs-N1 |
2.696600E-01 |
| Normal-vs-N2 |
4.937400E-01 |
| N0-vs-N1 |
2.881800E-03 |
| N0-vs-N2 |
1.263990E-02 |
| N1-vs-N2 |
7.694400E-01 |
|
|
